» Articles » PMID: 35928471

Selecting Euploid Embryos for Transfer by Preimplantation Genetic Testing with the Help of Next-Generation Sequencing in Poor Prognosis Patients: A Retrospective Cohort Analysis

Overview
Date 2022 Aug 5
PMID 35928471
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The current embryo selection methods rely on subjective grading of embryo morphology or a real-time monitoring of the embryonic development and assessment of multiple quantitative endpoints. Even up to 40% of morphologically normal embryos harbour aneuploidies. Preimplantation genetic testing (PGT) is a technology, which gives opportunity to identify euploid embryos before implantation.

Aims: This study seeks to determine the role of PGT in poor prognosis patients, i.e., patients with advanced maternal age (AMA) (maternal age ≥35 years), recurrent pregnancy loss (RPL) (miscarriages ≥2) and recurrent implantation failures (RIFs) ( fertilisation failures ≥3).

Study Setting And Design: A retrospective case-control study was done on a group of patients who underwent intracytoplasmic sperm injection for the indications of AMA, RPL and RIF.

Materials And Methods: In 33 cases who opted for PGT, day 5 blastocysts were subjected to trophectoderm biopsy with the help of next-generation sequencing. Euploid blastocyst was transferred in hormone replacement cycle at a later date. In 154 controls, blastocyst transfer was done based on morphological grading. Pregnancy outcomes are compared in terms of implantation rate, pregnancy rate, miscarriage rate and multiple pregnancy rate.

Statistical Analysis: Chi-square test was used for comparisons between the study groups with respect to percentage. < 0.05 was considered statistically significant.

Results: The highest aneuploidy rate was found in embryos with AMA. Implantation rate was found to be statistically significantly higher in the PGT group as compared to the non-PGT group. However, take-home baby rates were not improved by PGT. There were less number of mean embryos transferred in the PGT group and lower multiple pregnancy rate.

Conclusions: With the application of PGT, embryo selection rates and implantation rates improved in poor prognosis patients.

Citing Articles

Revolutionized attitude toward recurrent pregnancy loss and recurrent implantation failure based on precision regenerative medicine.

Motlagh Asghari K, Novinbahador T, Mehdizadeh A, Zolfaghari M, Yousefi M Heliyon. 2024; 10(20):e39584.

PMID: 39498089 PMC: 11532865. DOI: 10.1016/j.heliyon.2024.e39584.


A Comprehensive Review of the Endometrial Receptivity Array in Euploid Embryo Transfer Cycles.

Sharma M, Dubey P, Sunda U, Tilva H Cureus. 2024; 16(6):e63173.

PMID: 39070514 PMC: 11282320. DOI: 10.7759/cureus.63173.

References
1.
Brezina P, Kutteh W . Classic and cutting-edge strategies for the management of early pregnancy loss. Obstet Gynecol Clin North Am. 2014; 41(1):1-18. DOI: 10.1016/j.ogc.2013.10.011. View

2.
McCoy R . Mosaicism in Preimplantation Human Embryos: When Chromosomal Abnormalities Are the Norm. Trends Genet. 2017; 33(7):448-463. PMC: 5484399. DOI: 10.1016/j.tig.2017.04.001. View

3.
Sato T, Sugiura-Ogasawara M, Ozawa F, Yamamoto T, Kato T, Kurahashi H . Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure. Hum Reprod. 2019; 34(12):2340-2348. DOI: 10.1093/humrep/dez229. View

4.
Munne S, Chen S, Fischer J, Colls P, Zheng X, Stevens J . Preimplantation genetic diagnosis reduces pregnancy loss in women aged 35 years and older with a history of recurrent miscarriages. Fertil Steril. 2005; 84(2):331-5. DOI: 10.1016/j.fertnstert.2005.02.027. View

5.
Jobanputra V, Sobrino A, Kinney A, Kline J, Warburton D . Multiplex interphase FISH as a screen for common aneuploidies in spontaneous abortions. Hum Reprod. 2002; 17(5):1166-70. DOI: 10.1093/humrep/17.5.1166. View